Regulatory And HTA Alignment Key To Attracting Investors To UK
The COVID-19 pandemic has offered lessons on how collaboration can get important treatments to patients more quickly.
You may also be interested in...
Proposals extend the health technology appraisal body's focus beyond final guidance to support for early development and real world performance.
Following a Brexit-induced delay over the summer, England's HTA body NICE has come up with a concrete set of proposals that it says will help it “robustly and efficiently” evaluate innovative technologies such as advanced therapies, histology-independent cancer treatments, and technologies for rare diseases. Industry bodies have welcomed the plans, which have just been put out for consultation.
The European Parliament and EU Council have reached an agreement on taking forward proposals for greater cooperation on health technology assessments.